Obesity
7,393
642
940
4,885
Key Insights
Highlights
Success Rate
94% trial completion (above average)
Published Results
850 trials with published results (11%)
Research Maturity
4885 completed trials (66% of total)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
4.0%
293 terminated out of 7393 trials
94.3%
+7.8% vs benchmark
9%
650 trials in Phase 3/4
17%
850 of 4885 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 4885 completed trials
Clinical Trials (7393)
Maridebart Cafraglutide Versus Placebo in Adult Participants With Obstructive Sleep Apnea on Positive Airway Pressure Therapy
A Master Protocol for Orforglipron (LY3502970) in Participants With Obesity or Overweight With and Without Type 2 Diabetes
Evaluation of the Impact of Physical Reconditioning Associated With Specific Nutritional Supplementation in Obese Patients Suffering From Metabolic Syndrome
Patients Navigators in Facilitating Weight Management in Obese Participants
A Natural History of Genetic and Environmental Predictors of Pubertal Timing Among Youth With Obesity
Trial of the Combination of Alpha-Lipoic Acid and Mirabegron in Women and in Men With Obesity
Heart Health Study in Washington D.C. to Develop a Community-Based Behavioral Weight Loss Intervention
Prospective Evaluation of Adjusted Body Weight Dosing of Acyclovir in Obesity
AMAZE 2: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Type 2 Diabetes Lose Weight
Disulfiram in Rheumatoid Arthritis
Evaluation of the Clinical Spectrum of Diabetes and Obesity in Youth and Adults
GLP-1R Actions on Muscle and the Skeleton
Full Plate Living Nutrition Education Program
A Study of Orforglipron (LY3502970) in Participants With Obesity or Overweight and at Least One Weight-Related Comorbidity
Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity
A Study to Evaluate the Effect of Fasting Duration and Tirzepatide Withholding on the Amount of Food and Fluid in the Stomach in Participants With Type 2 Diabetes Mellitus and Participants With Overweight or Obesity Without Type 2 Diabetes Mellitus
Negative Pressure Wound Therapy in Healing Abdominal Incision in Obese Patients Undergoing Breast Reconstruction Surgery
Reflux Disease After Gastric Bypass Versus Sleeve Gastrectomy in Morbid Obese Patients: an Italian Study
Children s Growth and Behavior Study
Diabetes Prevention Program With or Without Hunger Training in Helping to Lower Breast Cancer Risk in Obese Participants